"Autoimmune HIT" antibodies in diagnostic samples are a potential artifact and not associated with more severe outcomes
Blood Adv
.
2023 Aug 22;7(16):4431-4434.
doi: 10.1182/bloodadvances.2023009811.
Authors
Adam J Kanack
1
,
Janhavi Athale
2
,
Rachel R Leger
1
,
Abdul Saadalla
3
,
Nahla M Heikal
1
,
Dong Chen
1
,
David A Garcia
4
,
Ravinder Singh
1
,
Rajiv K Pruthi
5
,
Anand Padmanabhan
1
Affiliations
1
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
2
Department of Critical Care Medicine, Mayo Clinic, Phoenix, AZ.
3
Department of Pathology, University of Utah, Salt Lake City, UT.
4
Department of Medicine, University of Washington, Seattle, WA.
5
Department of Medicine, Mayo Clinic, Rochester, MN.
PMID:
37267446
PMCID:
PMC10440464
DOI:
10.1182/bloodadvances.2023009811
No abstract available
Publication types
Research Support, N.I.H., Extramural
MeSH terms
Artifacts*
Autoantibodies*
Heparin
Substances
Autoantibodies
Heparin
Grants and funding
R01 HL158932/HL/NHLBI NIH HHS/United States